OncoPro 350 Gene TMB MSI Profile Test
Comprehensive Cancer Genetic Analysis for Personalized Treatment
The OncoPro 350 Gene TMB MSI Profile Test represents a cutting-edge advancement in cancer diagnostics, utilizing next-generation sequencing technology to provide comprehensive genomic profiling of tumor tissue. This sophisticated test analyzes 350 cancer-related genes, offering unprecedented insights into the molecular drivers of cancer and enabling precision medicine approaches that can significantly improve patient outcomes.
What This Advanced Test Measures
The OncoPro 350 Gene TMB MSI Profile Test provides a multi-faceted analysis of tumor genetics through several key components:
- 350 Cancer Gene Panel: Comprehensive sequencing of 350 genes known to be involved in cancer development and progression
- Tumor Mutational Burden (TMB): Quantitative assessment of the total number of mutations per megabase of DNA, a crucial biomarker for immunotherapy response
- Microsatellite Instability (MSI): Evaluation of DNA mismatch repair deficiency, another important predictor of immunotherapy efficacy
- Genetic Alterations: Detection of single nucleotide variants, insertions, deletions, copy number variations, and gene fusions
- Biomarker Identification: Recognition of specific genetic markers that may indicate susceptibility to targeted therapies
Who Should Consider This Test
The OncoPro 350 Gene TMB MSI Profile Test is particularly valuable for patients with:
- Advanced or metastatic solid tumors requiring comprehensive genomic profiling
- Cancers that have progressed on standard treatments and need alternative therapeutic options
- Rare or uncommon cancer types where standard testing may be insufficient
- Cancers with unknown primary origin requiring molecular characterization
- Patients being considered for immunotherapy who need TMB and MSI status evaluation
- Individuals with family history of cancer seeking comprehensive tumor profiling
Key Benefits of Comprehensive Genomic Testing
Undergoing the OncoPro 350 Gene TMB MSI Profile Test offers numerous advantages for cancer patients and their healthcare providers:
- Personalized Treatment Planning: Identifies specific genetic alterations that can be targeted with precision medicines
- Immunotherapy Guidance: Provides TMB and MSI status to predict response to immune checkpoint inhibitors
- Clinical Trial Matching: Identifies eligibility for targeted therapy clinical trials based on specific genetic markers
- Comprehensive Analysis: Single test replaces multiple individual genetic tests, saving time and tissue samples
- Prognostic Information: Offers insights into cancer aggressiveness and potential treatment resistance
- Cost-Effective Approach: Comprehensive testing at $1756 USD provides exceptional value compared to multiple individual tests
Understanding Your Test Results
Your OncoPro 350 Gene TMB MSI Profile Test results will provide detailed information in several key areas:
- Genetic Alterations: Specific mutations identified in the 350 cancer genes analyzed
- TMB Classification: Your tumor will be classified as TMB-high, TMB-intermediate, or TMB-low based on established thresholds
- MSI Status: Determination of microsatellite stability (MSS) or instability (MSI-High)
- Actionable Findings: Identification of genetic alterations with available targeted therapies or clinical trials
- Interpretive Summary: Comprehensive explanation of findings and their clinical implications
Your oncologist will review these results with you and discuss how they impact your treatment options, including potential eligibility for targeted therapies, immunotherapies, or clinical trials.
Test Pricing and Details
| Test Component | Price (USD) |
|---|---|
| Discount Price | $1756 |
| Regular Price | $1950 |
| Turnaround Time | 45 Working Days |
| Sample Type | Formalin Fixed Paraffin Embedded (FFPE) Tissue Block |
| Sample Requirements | Minimum 10% tumor tissue content |
Nationwide Availability and Booking
We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network ensures that patients nationwide have access to this advanced cancer genomic testing.
To schedule your OncoPro 350 Gene TMB MSI Profile Test or to speak with one of our genetic counselors about whether this test is right for you, please call us at +1(267) 388-9828 or use our online booking system. Our team is available to answer your questions and guide you through the testing process, from sample collection to result interpretation.
Take the next step in your cancer journey with comprehensive genomic insights. Book your OncoPro 350 Gene TMB MSI Profile Test today and empower your treatment decisions with cutting-edge genetic information.
